Oxidase activity of ceruloplasmin and some acute phase reactant and trace element concentrations in serum of patients with chronic lymphocytic leukemia

Scottish Medical Journal

Volumn 52, Issue 1, 2007, Pages 24-27

  Gundogdu, Mehmet ^a   Kaya, H ^b   Gulcin, I ^c   Erdem, F ^a   Cayir, K ^a   Keles, M ^a   Yilmaz, A ^c  

^a ATATURK UNIVERSITY   (Turkey)

^b MUSTAFA KEMAL UNIVERSITY   (Turkey)

^c Nenehatun Obstetric and Gynecology Hospital ^*  (Turkey)

Author keywords

Acute phase proteins; Albuminumin; Ceruloplasmin; Chronic lymphocytic leukaemia; Oxidase activity; Transferrin

Indexed keywords

ACUTE PHASE PROTEIN; ALBUMIN; CERULOPLASMIN; COPPER; MANGANESE; OROSOMUCOID; OXIDOREDUCTASE; TRACE ELEMENT; TRANSFERRIN; ZINC;

ADULT; AGED; ARTICLE; BLOOD LEVEL; CANCER STAGING; CERULOPLASMIN BLOOD LEVEL; CHRONIC LYMPHATIC LEUKEMIA; CLINICAL ARTICLE; CONTROLLED STUDY; COPPER BLOOD LEVEL; CORRELATION ANALYSIS; ENZYME ACTIVITY; FEMALE; HUMAN; MALE; STATISTICAL SIGNIFICANCE; TRANSFERRIN BLOOD LEVEL; ZINC BLOOD LEVEL;

EID: 33947154686     PISSN: 00369330     EISSN: None     Source Type: Journal    
DOI: 10.1258/rsmsmj.52.1.24     Document Type: Article

References (25)

1. Bennett JC, Plum F. Eds. Cecil Textbook of Medicine. 20th ed. Philadelphia: W.B Saunders Company, 1996. 931-55.
2. Bakan N, Taysi S, Yilmaz Ö et al. Glutathione peroxidase, glutathione reductase, superoxide dismutase activies, glutathione, nitric oxide, and malondialdehyde levels in serum of patients with chronic lymphocytic leukaemia. Clin Chem Acta 2003; 338: 143-9.
3. Cheson BD. Chronic Lymphoid Leukemias, New York: Marcel Dekker, 1993. 33-62
4. Yang J, Lam EWN, Hammad HM et al. Antioxidant enzyme levels in oral squamous cell carcinoma and human oral epithelium. J Oral Pathol Med. 2002; 31: 71-7
5. Koc M, Taysi S, Sezen O et al. Levels of some acute phase protein in serum of patients with cancer during radiotherapy. Biol Pharm Bull. 2003; 26: 1494-7
6. Lee SY, Lim JW, Kim YM et al. Induction of a-1-acid glycoprotein mRNA by cytokines and differentiation in human colon carcinoma cell. Mol Cells 2001; 11: 164-9
7. Uslu C, Taysi S, Akcay F et al. Levels of alpha-1-acid glycoprotein, free, and bound sialic acid in serum of patients with laryngeal cancer. Ann Clin Lab Sci 2003; 33: 156-9
8. Young IS, Woodside JV. Antioxidants in health and disease. J Clin Pathol. 2001; 54:176-86
9. Memisogullari R, Taysi S, Bakan E et al. Antioxidant status and lipid peroxidation in type II diabetes mellitus. Cell Biochem Funct. 2003; 21: 291-6
10. Taysi S, Kocer I, Memisogullari R et al. Serum oxidant/antioxidant status in serum of patients with Behçet' Disease. Ann Clin Lab Sci 2002; 32: 377-82
11. Cogalgil S, Taysi S. Levels of antioxidant proteins and soluble intercellular adhesion molecule-1 in serum of patients with rheumatoid arthritis. Ann Clin Lab Sci 2002; 32: 264-70
12. Zowczak M, Iskra M, Paszkowski J et al. Oxidase activity of ceruloplasmin and concentrations of copper and zinc in serum of cancer patients. J Trace Elem Med Biol. 2001; 15: 193-6
13. Taysi S, Gul M, Sari RA et al. Oxidant/antioxidant status in serum of patients with systemic lupus erythematosus. Clin Chem Lab Med 2002; 40: 684-8
14. Aksoy H, Taysi S, Attinkaynak K et al. Antioxidant potential and transferrin, ceruloplasmin and lipid peroxidation lavels in women with preeclampsia. J Investig Med. 2003; 51: 284-7
15. Keles MS, Taysi S, Sen N et al. Effect of corticosteroid therapy on serum and CSF malondialdehyde and antioxidant proteins in multiple sclerosis. Can J Neurol Sci 2001; 28: 141-3
16. Taysi S, Akcay F, Uslu C et al. Trace elements and some extracellular antioxidant proteins Levels in serum of patients with laryngeal cancer. Biol Trace Elem Res 2003; 91: 11-8
17. Rai KR, Stawitsky A, Cronkite EP et al. Clinical staging of chronic lymphocytic leukaemia. Blood 1975; 46: 941-5
18. Schosinski KH, Leman HP, Balbuminer MF. Measurement of cerulopasmin from oxidase activity in serum by use of o-dianizidine. Clin Chem 1974; 20: 5556-60
19. Agroyannis B, Dalamangas A, Dardouphas K et al. Serum transferrin and ceruloplasmin in patients with cancer at the gastrointestinal and other systems. Anticancer Res 1994; 14: 2201-3
20. Varela AS, Lopez Saez JJ, Quintela Senra B. Serum ceruloplasmin as a diagnostic marker of cancer. Cancer Lett 1997; 121: 139-45
21. Lee SY, Lim JW, Kim YM. Effect of a-1-acid glycoprotein expressed in cancer cells on malignant characteristics. Mol Cells 2001; 11: 341-5
22. Zago MP, Oteiza PI. The antioxidant properties of zinc: Interactions with iron and antioxidants. Free Rad Biol & Med 2001; 31: 266-74
23. Sattar N, Scott HR, McMillan DC et al. Acute-phase reactants and plasma trace element concentrations in non-small cell lung cancer patients and controls. Nutr Cancer. 1997; 28: 308-12
24. Arumanayagam M, Wong FW, Rogers M et al. Serum ceruloplasmin, Plasma copper concentration and copper to ceruloplasmin ration in cervical carcinoma. Gynecol Obstet Invest 1993; 35: 175-8
25. Magalova T, Bella V, Brtkova A et al. Copper, zinc and superoxide dismutase in precancerous, benign diseases and gastric, colorectal and breast cancer. Neoplasma 1999; 46: 100-4